Intercept Pharma (ICPT) Announces Presentation of Data from Three Ocaliva Phase 3 Analyses
Tweet Send to a Friend
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) announced results from three new exploratory analyses of the Phase 3 POISE trial of Ocaliva® ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
